Nicotine therapeutic benefits: Difference between revisions
Jump to navigation
Jump to search
(Added Huntington’s Disease) |
(added link to study) |
||
Line 416: | Line 416: | ||
===2012: The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition=== <!--T:93--> | ===2012: [https://pubmed.ncbi.nlm.nih.gov/22503574/ The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition]=== <!--T:93--> | ||
<!--T:94--> | <!--T:94--> | ||
Line 424: | Line 424: | ||
*[https://sci-hub.se/10.1016/j.addbeh.2012.03.004 PDF Version] | *[https://sci-hub.se/10.1016/j.addbeh.2012.03.004 PDF Version] | ||
*Citation: Dawkins, L., Turner, J., Hasna, S., & Soar, K. (2012). The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition. Addictive Behaviors, 37(8), 970–973. doi:10.1016/j.addbeh.2012.03.004 | *Citation: Dawkins, L., Turner, J., Hasna, S., & Soar, K. (2012). The electronic-cigarette: Effects on desire to smoke, withdrawal symptoms and cognition. Addictive Behaviors, 37(8), 970–973. doi:10.1016/j.addbeh.2012.03.004 | ||
*Electronic Cigarette Company (TECC) supplied the e-cigarettes and cartridges for this study. TECC had no involvement in the design or conduct of the study. | *Electronic Cigarette Company (TECC) supplied the e-cigarettes and cartridges for this study. TECC had no involvement in the design or conduct of the study. | ||
<br> | |||
===2003 [https://www.nature.com/articles/1300202 Psychoactive Drugs and Pilot Performance: A Comparison of Nicotine, Donepezil, and Alcohol Effects]=== <!--T:95--> | ===2003 [https://www.nature.com/articles/1300202 Psychoactive Drugs and Pilot Performance: A Comparison of Nicotine, Donepezil, and Alcohol Effects]=== <!--T:95--> |